Why did you decide to pivot from enzyme manufacturing to biopharmaceuticals?
Replied byKiran Mazumdar-Shaw
Founder & Executive Chairperson at Biocon
Niche: Health & Wellness
Revenue: Approx. $172 Million/month
Location: Bengaluru, Karnataka, India
Started: 1978
I like to challenge myself and reinvent my business. Around 1996, I decided to apply our fermentation platforms to pharmaceuticals. We successfully produced statins, capturing a significant share of the global active pharmaceutical ingredient market, and then began targeting recombinant human insulin.
0
From the Full Interview
This answer is part of a full interview with Kiran Mazumdar-Shaw, Founder & Executive Chairperson at Biocon.
Share this Answer
Found this insight valuable? Share it with your network to help others learn from Kiran Mazumdar-Shaw's experience.
Cite This Answer
Use this answer in your research, article, or academic work
Related Answers
How did you feel when you generated thousands of pounds in ten minutes from your first PDF launch?
By Krissy Cela
Health & Wellness
Approx. 16.6 Million USD/mo
How did you transition from being a personal brand to a global activewear company?
By Krissy Cela
Health & Wellness
Approx. 16.6 Million USD/mo
Why did you decide to bring in Zach as a CEO after reaching fifty million dollars in revenue?
By Krissy Cela
Health & Wellness
Approx. 16.6 Million USD/mo
How did Stanley the dog transition from a brand antagonist into a disciplined optimist?
By Adrian Gore
Health & Wellness
Approx. 400 Million/mo
How did you make the transition from brewing to founding a biotechnology startup?
By Kiran Mazumdar-Shaw
Health & Wellness
Approx. $172 Million/mo
How has Chapter attracted investors from different political and professional backgrounds?
By Cobi Blumenfeld-Gantz
Health & Wellness
Approx. 8.3 Million/mo
Why did you move from medicine and research into entrepreneurship?
By Dr Emil Kendziorra
Health & Wellness
$50K-$250K/mo